ICD-10-CM Billable Code

D3A.096

Benign carcinoid tumor of the hindgut, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the hindgut is a non-cancerous growth that develops in the part of the digestive system known as the hindgut, which includes the rectum and the lower part of the colon. While these tumors are typically slow-growing and less aggressive than other types of cancer, they require medical evaluation and monitoring to ensure they do not cause complications or develop into malignant forms. Understanding the nature of this condition can help patients better grasp their diagnosis and available management options.

Causes & Symptoms

Clinical Causes: Genetic factors that predispose individuals to neuroendocrine tumor formation Family history of carcinoid tumors or other neuroendocrine tumors Previous radiation therapy or exposure to certain chemicals that may affect the gastrointestinal tract Rare cases linked to other neuroendocrine syndromes or conditions

Key Symptoms: Often asymptomatic, especially in early stages Rectal bleeding or blood in the stool Persistent constipation or change in bowel habits Abdominal pain or discomfort Feeling of fullness or bloating in the abdomen Unexplained weight loss or fatigue in some cases

Diagnostic & Treatment

Diagnosis Path: The diagnosis of a benign carcinoid tumor in the hindgut typically involves several steps: - Medical history review and physical examination - Endoscopic procedures, such as colonoscopy, to visualize the tumor directly and obtain tissue samples - Imaging studies like CT scans or MRI to assess the extent of the tumor and check for spread - Biopsy of the tumor tissue to confirm the benign nature of the growth Laboratory tests may include blood and urine tests for hormone levels related to neuroendocrine activity, although imaging and histopathology are central to diagnosis.

Treatment Protocols: Management of a benign carcinoid tumor in the hindgut often depends on the size, location, and specific characteristics of the tumor: - **Surgical removal** is the primary treatment, often involving local excision or more extensive surgery if needed - Regular follow-up with endoscopic and imaging studies to monitor for recurrence or growth - In some cases, if the tumor produces hormones causing symptoms, medications such as somatostatin analogs may be used to control hormonal effects - Less common approaches might include minimally invasive procedures or watchful waiting if the tumor is small and not causing symptoms Patients are advised to discuss personalized management strategies with their healthcare team, considering the benign nature of the tumor and individual health factors.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.096 a billable ICD-10 code?
Yes, D3A.096 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.096?
Clinical documentation must specify the nature of Benign carcinoid tumor of the hindgut, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference